cardiomyopeptidin
Animal productexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
3
Earliest trial started Jun 1, 2019 (NCT03958422)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06117046 | Phase 4 | Feb 27, 2023 | Southern Medical University |
| NCT06155110 | Phase 4 | Mar 1, 2022 | Dalian Zhen-Ao Bio-Tech Co., Ltd., People's Liberation Army of China |
| NCT03958422 | Phase 4 | Jun 1, 2019 | Dalian Zhen-Ao Bio-Tech Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dalian Zhen-Ao Bio-Tech Co., Ltd. | For profit | 2 | 1 | 1 | 2019 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2022 |
| Southern Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
3 organizations
Page 1 / 1